Aptar Named One of America's Most Responsible Companies by Newsweek for the Seventh Consecutive Year

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Named One of America's Most Responsible Companies by Newsweek for the Seventh Consecutive Year.

Business Wire • Dec 4, 2025

Is the Options Market Predicting a Spike in AptarGroup Stock?

Investors need to pay close attention to ATR stock based on the movements in the options market lately.

Zacks Investment Research • Dec 3, 2025

Aptar Strengthens Latin America Footprint With Sommaplast Buy

On Monday, AptarGroup, Inc. (NYSE: ATR) acquired Sommaplast, a specialized provider of oral dosing pharma packaging solutions, such as closures, droppers, dispensers, and dosing cups, based in Brazil.

Benzinga • Dec 2, 2025

Touchstone Mid Cap Fund Q3 2025 Portfolio Review

The Touchstone Mid Cap Fund (Class A Shares, Load Waived) underperformed its benchmark, the Russell MidCap® Index, for the quarter ended September 30, 2025. Among the largest contributors to Fund performance were Somnigroup International, Inc. (Consumer Discretionary sector), Armstrong World Industries, Inc. (Industrials sector), and NewMarket Corporation (Materials sector). Among the largest detractors from Fund performance were Fidelity National Information Services, Inc. (Financials sector), Allison Transmission Holdings, Inc. (Industrials sector), and AptarGroup, Inc. (Materials sector).

Seeking Alpha • Nov 24, 2025

AptarGroup, Inc. (ATR) Presents at Jefferies London Healthcare Conference 2025 Transcript

AptarGroup, Inc. ( ATR ) Jefferies London Healthcare Conference 2025 November 19, 2025 7:00 AM EST Company Participants Stephan Tanda - President, CEO & Executive Director Gael Touya - President of Aptar Pharma Vanessa Kanu - Executive VP & CFO Conference Call Participants Daniel Rizzo - Jefferies LLC, Research Division Presentation Daniel Rizzo Jefferies LLC, Research Division Good afternoon. I am Dan Rizzo with Jefferies Equity Research.

Seeking Alpha • Nov 19, 2025

Aptar to Present at Jefferies Global Healthcare Conference on November 19, 2025

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar to Present at Jefferies Global Healthcare Conference on November 19, 2025.

Business Wire • Nov 11, 2025

AptarGroup: Pharma Setback Creates Long-Term Opportunities

AptarGroup's shares have dropped over 25% from summer highs due to slower growth, especially in high-margin pharma emergency solutions. ATR's valuation has compressed from 26x to 20x earnings, reflecting concerns about flat growth and a soft outlook for 2026. Pharma remains the most profitable segment, but headwinds in emergency-use delivery systems are expected to impact revenues next year.

Seeking Alpha • Nov 2, 2025

AptarGroup, Inc. (ATR) Q3 2025 Earnings Call Transcript

AptarGroup, Inc. ( ATR ) Q3 2025 Earnings Call October 31, 2025 9:00 AM EDT Company Participants Marry Skafidas - Senior Vice President of Investor Relations & Communications Stephan Tanda - President, CEO & Executive Director Vanessa Kanu - Executive VP & CFO Conference Call Participants Ghansham Panjabi - Robert W. Baird & Co. Incorporated, Research Division Paul Knight - KeyBanc Capital Markets Inc., Research Division George Staphos - BofA Securities, Research Division Matthew Larew - William Blair & Company L.L.C.

Seeking Alpha • Oct 31, 2025

Aptar Reports Third Quarter 2025 Results

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Reports Third Quarter 2025 Results.

Business Wire • Oct 30, 2025

AptarGroup (ATR) Q3 Earnings and Revenues Top Estimates

AptarGroup (ATR) came out with quarterly earnings of $1.62 per share, beating the Zacks Consensus Estimate of $1.57 per share. This compares to earnings of $1.49 per share a year ago.

Zacks Investment Research • Oct 30, 2025